Education
About Us
Working with TipRanks
Follow Us
Vicapsys Life Sciences (VICP)
:VICP
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -31.29K | $ -31.33K | $ -31.42K | $ -31.30K |
| Operating Income | $ -1.05M | $ -984.79K | $ -336.87K | $ -765.84K | $ -1.03M |
| EBITDA | $ -1.05M | $ -984.79K | $ -305.54K | $ -734.42K | $ -1.00M |
| Net Income | $ -1.18M | $ -1.67M | $ -136.87K | $ -765.84K | $ -1.41M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 9.42K | $ 14.10K | $ 217.29K | $ 1.27K | $ 264.17K |
| Total Assets | $ 39.66K | $ 72.02K | $ 594.31K | $ 404.12K | $ 698.44K |
| Total Debt | $ 353.87K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 344.45K | $ -14.10K | $ -217.29K | $ -1.27K | $ -264.17K |
| Total Liabilities | $ 1.97M | $ 1.02M | $ 715.96K | $ 853.22K | $ 396.48K |
| Stockholders' Equity | $ -1.93M | $ -950.79K | $ -121.65K | $ -449.11K | $ 301.96K |
| Cash Flow | |||||
| Free Cash Flow | $ -417.52K | $ -238.20K | $ -443.97K | $ -262.90K | $ -970.26K |
| Operating Cash Flow | $ -417.52K | $ -238.20K | $ -443.97K | $ -262.90K | $ -970.26K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 100.00K | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 412.85K | $ 35.00K | $ 560.00K | $ 0.00 | $ 1.15M |
Vicapsys Life Sciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.